Accord Healthcare, Inc. has issued a consumer-level, nationwide recall of a single lot (PW05264) of mislabeled hydrochlorothiazide 12.5 mg tablets, per U.S. Food and Drug Administration (FDA). It was discovered, through a patient complaint, that a 100-count bottle hydrochlorothiazide contains 100 spironolactone 25 mg tablets.
Similar to hydrochlorothiazide, spironolactone is also used as a blood pressure drug. However, the use of spironolactone could increase potassium levels, which could be fatal for some patients. It could even cause arrhythmia when taken in larger doses. It is also used to treat liver, heart and kidney failure, according to the FDA. Aldactone and CaroSpir are the brand names that spironolactone is sold in, per NBC News.
As of now, there are no reports of patients getting sick because of this mishap.
Accord believes that no other lots of hydrochlorothiazide have been affected by the mislabeling, however, it asks consumers to be more cautious especially if this drug is prescribed to them. The company also calls for wholesalers and distributors to halt the distribution of this drug and immediately notify their customers.
For guidance, FDA also included this description of the drug in its announcement: “Accord’s Hydrochlorothiazide Tablets USP 12.5 mg are light orange to peach colored, round, biconvex tablets debossed with H on one side and 1 on another side.”
Accord also encourages both consumers and distributors to contact them about this recall during business hours—Monday through Friday 8 a.m. to 5 p.m. EST. You can reach them by:
- phone: at 1-855-869-1081
- fax: 1-817-868-5362
- e-mail: email@example.com
Accord Healthcare, Inc. is a generic pharmaceutical company that develops and manufactures products for different areas of medicine. It serves consumers from North America, Europe, South America, Australia, New Zealand, South Africa and the MENA region.
The TopRanked.io Weekly Digest: What’s Hot in Affiliate Marketing [++ A2 Hosting Affiliates Review]
Something's brewing in the Right to Repair space. Lawmakers are increasingly law-making. DIY fixer upperers are increasingly fixer uppering. And,...
Why the Carbon Credit Market Is Not Working
The Carbon Brief analysis focused on 34 companies that alone used 38 million tons of carbon dioxide over the period...
Recrowd, Real Estate Lending Platform, Finally Gets European Authorization
Recrowd adopts a distinct approach for less sophisticated investors, limiting their investments to under €1,000 or 5% of their net...
Why the Amounts Invested in Belgian Fintech Companies Decreased
In 2023, the Belgian fintech sector has not witnessed any major fundraising events similar to those in previous years, such...
Bitcoin Soars 130% This Year: Will It Reach New All-Time Highs in 2024?
Bitcoin is currently trading within an ascending channel, maintaining support at $35,000, with an upward trajectory towards the psychological resistance...
Biotech2 weeks ago
Eli Lilly Builds a New Production Center with an Investment of $2.5 Billion
Markets7 days ago
Setting Aside the Magnificent Seven, Gold Has Been a Star Performer Since the Start of the Millennium
Biotech2 weeks ago
European Patent Office Invalidates Moderna’s RNA Solution
Crowdfunding6 days ago
“People Mobil Herzogenrath” Was Created Through Crowdfunding